Effect of NLR and MPV on Early Postoperative Outcome in Lower Extremity Arthroplasty Operations
Effect of Neutrophil /Lymphocyte Ratio (NLR) and Mean Platelet Volume (MPV) on Early Postoperative Outcome in Lower Extremity Arthroplasty Operations
1 other identifier
observational
754
1 country
1
Brief Summary
In the planned study the investigators want to evaluate the relation between postoperative complications and minor/ major morbidities, mortality and Mean Platelet Volume (MPV) and Neutrophil/ lymphocyte (N/L) ratio.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2017
CompletedFirst Posted
Study publicly available on registry
May 11, 2017
CompletedStudy Start
First participant enrolled
June 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2018
CompletedJanuary 13, 2023
January 1, 2023
7 months
May 2, 2017
January 12, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
postoperative VAS (visual analogue scale) score
postoperative visual analog scale score for pain evaluation 0,10,20,30,40,50,60,70,80,90,100)
VAS score at postoperative twenty-forth hours will be evaluated
Secondary Outcomes (2)
analgesic drugs
total dose of analgesic drugs required at twenty four hours will be evaluated
postoperative major morbidities
at postoperative first, sixth, twelfth and twenty-forth hours
Other Outcomes (1)
postoperative side effects
at postoperative first, sixth, twelfth and twenty-forth hours
Study Arms (4)
Group 1
Group 1: patients receiving general anesthesia and having a postoperative pain VAS score equal to or below 50 at 1st, 6th, 12th nd 24th hours the pain sores will be evaluated at 4 time intervals and so the number of patients in every group may change at every time interval.
Group 2
Group 2: patients receiving general anesthesia and having a postoperative pain VAS score equal to or above 60 at 1st, 6th, 12th nd 24th hours the pain sores will be evaluated at 4 time intervals and so the number of patients in every group may change at every time interval.
Group 3
Group 3: patients receiving regional (spinal) anesthesia and having a postoperative pain VAS score equal to or below 50 at 1st, 6th, 12th nd 24th hours the pain sores will be evaluated at 4 time intervals and so the number of patients in every group may change at every time interval.
Group 4
Group 4: patients receiving spinal anesthesia and having a postoperative pain VAS score equal to or above 60 at 1st, 6th, 12th nd 24th hours the pain sores will be evaluated at 4 time intervals and so the number of patients in every group may change at every time interval.
Eligibility Criteria
All consecutive patients undergoing knee arthroplasty in 3 years period with general or spinal anesthesia.
You may qualify if:
- knee arthroplasty patients with general or spinal anesthesia.
You may not qualify if:
- patients not giving consent
- reoperations
- patients having inflammatory disease
- infection in the knee
- sepsis
- bleeding disorders
- hematologic diseases,
- using steroids.
- trauma
- fracture patients,
- bilateral knee prothesis
- combined surgery procedures
- patients needing perioperative transfusions
- uncooperative patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AkdenizU
Antalya, 07058, Turkey (Türkiye)
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ilker o Aycan, asso prof
Akdeniz University Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associated Professor
Study Record Dates
First Submitted
May 2, 2017
First Posted
May 11, 2017
Study Start
June 28, 2017
Primary Completion
January 31, 2018
Study Completion
January 31, 2018
Last Updated
January 13, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share